Life demands excellence
magazine â€“ winter 2011
A royal celebration
The Duke and Duchess of Cambridge open our new childrenâ€™s cancer centre
CyberKnife gets to work Granard House reopens
04 Whatâ€™s inside
at The Royal marsden, we deal with cancer every day, so we understand how valuable life is. and when people entrust their lives to us, they have the right to demand the very best. Thatâ€™s why the pursuit of excellence lies at the heart of everything we do.
Contents 12 CyberKnife stories The first Royal Marsden CyberKnife patients share their experiences
14 A royal opening A very special day marks the opening of the Oak Centre for Children and Young People
20 Private view Take a tour of Granard House, our state-of-the-art private care facility
Regulars 04 Hospital news 10 Cancer in focus 22 Day in the life 24 Fundraising 26 The Friends 27 PCAG 28 Foundation news 30 Puzzles & prizes
to the winter edition of Rm, The Royal marsdenâ€™s magazine for our staff, patients, carers and Foundation Trust members. in this special edition, we have full coverage of the recent visit by The Duke and Duchess of Cambridge to open our new Oak Centre for Children and Young People. i am delighted that they chose The Royal marsden as one of their few official engagements since their wedding in april, and it proved to be a really enjoyable visit for all those involved. We also hear from two of our first CyberKnife patients, celebrate our successful Biomedical Research Centre bid and review the recent radiotherapy advertising campaign. i hope you enjoy this issue.
Cally Palmer, Chief executive, The Royal marsden
RM magazine 03
hospital News Key Biomedical Research Centre highlights ◆ New prostate cancer drugs abiraterone and cabazitaxel have been developed through work at The Royal Marsden and the ICR ◆ 13 new drug candidates have been discovered and nominated for development at the ICR in the past five years ◆ Two START trials, led by The Royal Marsden, have resulted in tens of thousands of breast cancer patients per year needing fewer radiotherapy sessions ◆ Intensity-modulated radiation therapy (IMRT), developed at The Royal Marsden and the ICR, has improved precision and reduced side-effects in radiotherapy
Vital funding continues for cancer research he Royal marsden, together with our academic partner The institute of Cancer Research (iCR), has successfully bid to retain its status as the UK’s only Specialist Biomedical Research Centre (BRC) for Cancer. The Department of Health announced five further years of funding from the national institute for Health Research (niHR) in august this year. The BRC grant provides The Royal marsden and the iCR with £12million of funding each year for cancer research as part of an £800million government investment in medical research, the largest-ever investment into early-stage health research. The grant was awarded 04 RM magazine
thanks to our proven record of excellence in biomedical and translational research and researchers; our track record in translating advances in basic biomedical research into clinical research and benefits for patients, the public and the nHS; and our strategic partnerships. Professor Stephen Johnston, Director of Clinical Research and Development for The Royal
Our aim is to drive pioneering research into the prevention, diagnosis and treatment of cancer PROFessOR sTePHeN JOHNsTON
marsden and the iCR, said: “We’ve had some great results over the last five years in research and drug development, helped massively by the funding received from the first niHR grant. Our aim is to drive pioneering research into the prevention, diagnosis and treatment of cancer, and translate advances in biomedical research into patient benefits. This continued funding lets us progress these plans. Our research is also underpinned by investment in leading-edge facilities such as the Centre for molecular Pathology.” For more information about the BRC, watch a short film at royalmarsden.nhs.uk
◆ Sorafenib, a new renal cancer drug, has been developed following the discovery of BRAF mutations in cancer by ICR scientists ◆ Active Surveillance Policy, pioneered by the ICR and The Royal Marsden, is now included in National Institute for Clinical Excellence (NICE) guidance for early prostate cancer ◆ Aromatase inhibitors, the most effective form of endocrine treatment for hormone-positive breast cancer in postmenopausal women, were developed at The Royal Marsden
RM magazine reader survey
We’re running a reader survey to find out what you think about RM magazine. Let us know your thoughts at royalmarsden.nhs.uk/rmsurvey. One lucky survey entrant will win a £20 John Lewis voucher. ESMO Awards 2011
Top honour for innovaTive professor
professor David cunningham
new research faciliTy in The pipeline a new clinical wing, set to be built in Sutton and fully operational within the next three to four years, is to house a dedicated research area. Part of the Sutton site’s wider redevelopment plans, the bespoke building will house state-of-the-art technologies where patients on research protocols will be treated by dedicated research teams. “This is exciting for The Royal marsden and the development of cancer research,” says Professor David Cunningham, Head of the gi Unit and clinical lead on the project. “it will give us the opportunity to exploit the breakthroughs in developing new targets for the treatment of tumours by providing a dedicated research environment where we can evaluate new treatments with patients clinical trials. This will lead to improved survivorship outcomes.”
Building a better future Our recently completed or future projects will keep us at the cutting edge of cancer care: Sutton ◆ The Oak Centre for Children and Young People ◆ The Centre for Molecular Pathology ◆ The Clinical Treatment and Research Centre Chelsea ◆ Granard House private care facility ◆ CyberKnife Suite ◆ Rapid Diagnostic and Assessment Centre ◆ Critical Care Unit ◆ Ambulatory Care Centre ◆ Medical Day Unit
a prestigious european cancer award has been given to Professor Johann de Bono in recognition of his outstanding scientific accomplishments. The 2011 european Society for medical Oncology (eSmO) award was presented to Professor de Bono for his dedication to translational and clinical research, innovative treatment, education and development of international guidelines for prostate cancer management. a professor in experimental Cancer medicine and Honorary Consultant in medical Oncology at The Royal marsden and The institute of Cancer Research (iCR), Professor de Bono received the award at the annual eSmO multidisciplinary Cancer Congress in Stockholm, Sweden. The award, established in 1985, is voted on by an esteemed eSmO Fellowship and award Committee of renowned cancer leaders. Professor de Bono’s work at The Royal marsden and the iCR in clinical drugdevelopment phase-i trial programmes has led to the development of more than 100 novel agents. many of these are now approved drugs, including abiraterone and cabazitaxel for
advanced prostate cancer. “Our more customised clinical trial approach to each individual drug is bearing fruit,” said Professor de Bono. “We can now be confident that much will be accomplished in the years ahead. This award is a great encouragement and will spur me on to continue to serve cancer patients.” Professor Josep Tabernero, Chair of the eSmO Fellowship and award Committee, said: “Professor de Bono has undertaken exceptional work in oncology and has made important contributions to the development of new drugs in prostate cancer, particularly through excellence in translational research and study design.”
professor Johann de Bono (right)
RM magazine 05
media raises radiotherapy profile o complement the national Radiotherapy awareness initiative, which is working to raise the profile of radiotherapy as a vital cancer treatment, The Royal marsden launched a communications campaign in august. The campaign was part of a wider range of radiotherapy activities, including a round-table discussion chaired by Professor Sir mike Richards. a series of adverts in The Times and The Daily Telegraph raised awareness of the radiotherapy services provided at The Royal marsden and of the benefits of radiotherapy as
06â€‚ RM magazine
a treatment. These were supported by a series of patient films on the hospital website. as a leading radiotherapy provider, The Royal marsden is keen to help patients make an informed choice about where to be treated. We welcome nHS and private patients from across the UK and abroad. The campaign aimed to increase the number of referrals of private patients to the hospital coupled
In the first month, visits to the website were up 42 per cent
with an increased awareness of radiotherapy as a curative cancer treatment among the public and healthcare professionals. in the first month of the campaign, visits to The Royal marsden website were up by 42 per cent and visits to the radiotherapy-specific pages trebled, with almost 4,000 direct visits to the campaign landing page. Over 600 people viewed the radiotherapy patient videos on the website and more than 1,000 doctors visited our campaign microsite on doctors.net. For decades, The Royal marsden and our academic
partner The institute of Cancer Research have made pioneering research and treatment breakthroughs, such as intensity-modulated radiation therapy (imRT) and stereotactic body radiation therapy (SBRT). as world leaders in pioneering practice and research, we are well placed to inform a wider audience about advanced radiotherapy techniques. These include the new CyberKnife system at our Chelsea site, the latest in radiotherapy technology to be added to the range of groundbreaking treatments offered at the hospital.
The Royal Marsden looks to partner with local hospitals The Royal Marsden is currently supporting Ashford and St Peter’s Hospitals NHS Foundation Trust in its application to become the provider of services at Epsom Hospital in Surrey. Epsom and St Helier NHS Trust has decided to split and invited other Trusts to take over its services in a bid to ensure the highest quality care for patients in the Epsom and St Helier area. Ashford and St Peter’s would like to work with The Royal Marsden to manage cancer services on the Epsom site if its application is successful. The preferred provider will be announced in early 2012. The Royal Marsden is also considering how it can support the provision of cancer services at St Helier NHS Trust.
a patient’s perspective
This autumn, Dr Clare Shaw, Consultant Dietitian and Lead for Rehabilitation Research at The Royal marsden, presented findings from a year-long study into patients’ rehabilitation needs at the european multidisciplinary Cancer Congress. The study, led by Cathy Sandsund, allied Health Professional Researcher, explored patients’ views on their needs after treatment. its findings are being used to help The Royal marsden provide more tailored rehabilitation therapy services to patients. Other studies have identified that nearly a third of cancer patients have unmet rehabilitation needs, which may include advice and support about exercise, diet, returning to work or psychological issues. Patients who had undergone treatment for gynaecological or upper gastrointestinal cancer took part in focus groups. a key finding was that participants were unsure about what their ‘new normality’ would be following treatment; they discussed the barriers and facilitators to finding this. The three main areas covered were how the effects of cancer and treatment are felt physically and psychologically; how people adjust to a new situation; and what support is needed or received to get better. “it’s really important that we understand what patients want from us to help them recover their usual function after cancer
It’s really important that we understand what patients want to help them recover after treatment DR CLARe ShAw
treatment,” says Dr Shaw. “We are now undertaking an intervention study based on the thoughts and experiences that patients shared with us.” “You are not necessarily going to ask for rehabilitation therapies,” says patient Jacqueline Kennett, who took part in the research. “But, as with a good friend, you know it’s there. Those points of contact are so important.” another participant, Phaik Khim Oon, welcomed the chance to take part in the study. “going through the cancer treatment completely changes how you look at things in life, even down to your basic routine. i suppose it’s a process of getting back to normality.”
Find out more... Rehabilitation therapies at The Royal Marsden include the Lymphoedema Service, Nutrition and Dietetics, Occupational Therapy, Physiotherapy, Speech and Language Therapy, the Appliances Service and Complementary Therapy. The booklet ‘Your guide to support, practical help and complementary services’ is available at royalmarsden. nhs.uk/cancerinformation, from PALS or the Therapy Services Department. For more information on Therapy Services, call 020 7808 2811 (Chelsea) or 020 8661 3005/ 3028 (Sutton).
RM magazine 07
Prostate cancer breakthrough
success in cancer drug trial trial of a new cancer drug, which accurately targets tumours in bone, has been so successful that it has been stopped early. in the trial, led by Dr Chris Parker, prostate cancer patients with bone secondaries who were given a powerful alpha-radiation drug lived longer and experienced less pain and fewer side-effects. The trial of 922 people was stopped once it became clear that the drug was effective. The results were presented at the european multidisciplinary Cancer Congress in Stockholm in September. Radiation has been used to treat tumours for more than a century. it damages the genetic code inside cancerous cells. alpha particles are the big bruisers of the radiation world: they are helium nuclei, which are far bigger than beta dr chris Parker, consultant clinical Oncologist
radiation, a stream of electrons, or gamma waves. Dr Parker said: “alpha radiation is more damaging. Just one or two alpha particles can kill a cancer cell compared with thousands of hits for beta particles.” He added that alpha particles also do much less damage to surrounding tissue: “They have such a tiny range – a few millionths of a metre. We can be sure that the damage is being done where it should be.” in 90 per cent of patients with advanced prostate cancer, the tumour will have spread to the bone. Until now, treatment for bone secondaries has been limited to symptom control, rather than improving survival. The study looked at patients with these secondary cancers. The source of radiation – radium-223 – acts like calcium and sticks to bone. Two-thirds of patients
were given the radium-223 drug alongside the best standard treatment. The others received the best standard treatment and a dummy injection. The death rate was 30 per cent lower in the group taking radium-223. Those patients survived for 14 months on average compared with 11 months in the dummy group. The trial was abandoned in light of the early findings. “it would have been unethical not to offer the active treatment to those taking placebo,” said Dr Parker. “i think it will be a significant step forward for prostate cancer patients with bone secondaries.” Following this initial, phase-iii trial, future trials are planned and it is in the process of being approved for treatment. Until this process is complete, which may take around 12 months, it will not be available for patients.
I think it will be a significant step forward for prostate cancer patients with bone secondaries Dr chris parker, consultant clinical oncologist
08 RM magazine
Consultant award for performing 1,000th procedure The Royal Marsden’s Consultant Surgeon Chris Ogden (above) recently performed his 1,000th da Vinci ‘S’ robotic surgery procedure, more than any other surgeon in the UK. In recognition of his work, he was presented with the Intuitive Surgical UK Innovation Award by Chief Executive Cally Palmer in September. Chris is the only surgeon in the UK, and one of only 40 worldwide, to reach this number of procedures and be honoured with such an award. The da Vinci system is the most advanced way of treating prostate cancer: it can cut and manipulate tissue through a tiny hole, thereby reducing the pain and blood loss caused by open surgery. The patient’s hospital stay and recovery time is also reduced, as are life-changing side-effects. “I’ve done so many procedures that I don’t get nervous any more, but I never get complacent,” says Mr Ogden. “I focus on the job and on each patient as they come in. I think of their aims: they want to be cancer-free, potent and continent.”
research report goes digital The Joint annual Research Report from The Royal marsden and The institute of Cancer Research (iCR) has been produced as an online microsite rather than a printed document this year. The report highlights achievements and significant progress in cancer research made by the partnership between The Royal marsden and the iCR. Together, the organisations form europe’s largest comprehensive cancer centre, with an outstanding national and international reputation. Visit jointcancerreport.org/2011 to read this year’s report.
Anti-fraud checklist If you suspect fraud, do: ◆ make an immediate note of your concerns ◆ report your suspicions confidentially to someone with the appropriate authority and experience ◆ deal with the matter promptly Don’t: ◆ approach or accuse individuals directly ◆ try to investigate the matter yourself ◆ convey your suspicions to anyone other than those with the proper authority
hospital crackdown on fraud every nHS Trust in the country is required to have a Local Counter Fraud Specialist (LCFS) to help prevent fraud taking place in the hospital environment and protect taxpayers’ money. The LCFS for The Royal marsden is now Simon Spires from Parkhill. Simon took over this role in July 2011 and is available to speak to any member of staff in the strictest confidence. if you need to speak about or report any concerns regarding fraud or corruption within the Trust, contact Simon directly on 020 7953 3932 or email firstname.lastname@example.org – the most important thing to remember is, if you’re not sure, raise it.
Merging of charities On 1 September 2011, the Corporate Trustee of The Royal Marsden Hospital Charity (RMHC) transferred its assets, liabilities and functions to the Trustees of The Royal Marsden Cancer Charity (RMCC). This will make our charity administration easier and more efficient. The charitable activities of RMHC will continue to be undertaken by RMCC. Specific funds for research and for patient and staff amenities, for example, will be available as before, and capital and revenue grants to the hospital will continue to be made.
RM magazine 09
Cancer in focus
Professor John Shepherd, Consultant Surgeon
85%+ 55 survival rate for women under 40
Professor John Shepherd of the Gynaecology Unit discusses the causes and treatment of cervical cancer
How common is it? Worldwide, cervical cancer is the second most common cancer. it is the fifth most common cancer in women in the UK; this can be attributed to screening, earlier diagnosis and demographic factors. What are the causes? Human papillomavirus (HPV) is the major cause of cervical cancer. most women in the UK become infected with HPV at some time during their life, but the majority do not develop 10 RM magazine
of cases of women in their 30s are prevented by screening (75% for women in their 50s and 60s)
Q&A CerviCal CanCer
What is cervical cancer? There are two main types: squamous cell cervical cancer occurs in the layer of skin-like cells on the outer surface of the cervix – the narrow passage between the vagina and the womb – while adenocarcinoma affects the glandular cells lining the inside of the cervix. The area around the opening of the cervix is where cells are most likely to become cancerous – this is called the transformation zone. Other rare forms of cervical cancer can also occur.
cervical cancer – the virus causes no harm and goes away without treatment. However, smoking greatly increases the risk of getting cervical cancer. What are the symptoms? The most common symptom is vaginal bleeding at times other than menstruation, and severe discharge – but not all women have symptoms. How is it diagnosed? early cancers can be picked up with screening smears. Cervical screening (a smear test) has been available in the UK since 1967. it’s very important: cervical cancer is one of the few preventable cancers because pre-cancerous cell changes can be picked up before they have a chance to develop. a smear test involves taking a small sample of cells from the surface of the cervix. in england, it is recommended that all women between 25 and 64 have a smear test every three years. in the rest of the UK and in europe, USa and australia, it is recommended that women
start the screening process at the age of 20 or when they become sexually active. if a woman has abnormal symptoms at any age, she should seek medical advice. How is it treated? For pre-cancerous cells, a type of cone biopsy is performed after examining the cervix with a colposcope. For early invasive cancer, standard treatment is a radical hysterectomy or a combination of radiotherapy and chemotherapy. What developments are coming up? We have pioneered the radical trachelectomy operation at The Royal marsden. The aim of this procedure is to make it possible for a woman to still become pregnant by conserving the uterus for child bearing after removing the cervix. However, any pregnancy does require careful supervision. as with any cancer, careful assessment is necessary to select the most suitable form of treatment.
women are diagnosed with cervical cancer every week in the UK
1988 NHS Cervical Screening Programme set up
lower incident rates compared to 20 years ago
CancerStats: Key Facts June 2011, Cancer Research UK
Patient case study
Professor John shepherd cradles Helen Park’s newborn daughter alice (this picture); Helen with her ‘miracle baby’ (inset)
I was diagnosed with an ovarian cyst and had my ovary removed. Three days later, I was told I had cervical cancer
case study Helen Park
“When i first started experiencing bleeding between periods in my late 20s, i didn’t think it was unusual. Six months later, in January 2005, i was bleeding heavily and began to think something was wrong, but my local hospital’s a&e department put it down to a heavy period. “Three weeks later, i collapsed on my kitchen floor and was rushed to hospital, but again i was told it was a heavy
period. i knew this wasn’t right, so i urged the doctor to keep me in and investigate. i was diagnosed with an ovarian cyst and the doctor did a smear test. “in april 2005, i had my right ovary removed because the cyst had completely engulfed it. Just three days later, i was told i had cervical cancer. in hindsight, the ovarian cyst was a blessing in disguise as it meant that i had a smear earlier than planned. “i was told i would need an mRi scan and a hysterectomy. i had waited my whole life for children and not having a family of my own with my husband Richard was never an option. i was not about to let cancer get in my way. “as soon as i came home, i started searching the internet
for options – i could not believe a hysterectomy was my only choice. i came across The Royal marsden’s pioneering surgery for a radical trachelectomy. This operation can be performed if the cancer is caught early and has not spread from the cervix to the lymph nodes. “That summer, i was referred to The Royal marsden and Professor John Shepherd said i was suitable for surgery. During the operation, my whole cervix was removed and a permanent suture with a tiny hole was put in its place, offering me the chance to conceive naturally. “The operation took five hours. The surgeons used keyhole surgery to take some lymph nodes from my pelvis and tested them to ensure the cancer had
not spread. if it had, they would have performed the hysterectomy there and then. i was so relieved when they told me that the operation was successful and i did not need a hysterectomy. “in 2007, i fell pregnant. Sadly, at my 12-week scan, i was told it was a blighted ovum, where the embryo does not grow. i was devastated but determined to try again. i conceived again later that year, but miscarried at six weeks. “after two years of trying, i became pregnant for a third time. alice was born in July 2010 at 37 weeks by a planned Caesarean. i was considered high-risk because i had no cervix, which protects the baby from infection – but aside from one scare at 35 weeks, everything went really well. “alice is our miracle baby; i could not be happier. The support from the staff at The Royal marsden was incredible throughout my treatment, and every year when i go back for my check-ups, i am so grateful. “i urge all women to get to know their bodies – when things are not normal, get it checked out aSaP. i always tell my friends to go for their smear tests. it’s not comfortable or pleasant, but it could save your life.” rm RM magazine 11
Our first CyberKnife patients sing its praises In the previous issue, we revealed that CyberKnife, our new targeted radiotherapy machine, was up and running. Here, we catch up with some of the first patients to ask them about their experiences
ive years after completing treatment for prostate cancer, Ray Dean, 66, was given the devastating news that it had returned and that, due to the location of the tumour, his only curative treatment option was the groundbreaking robotic radiotherapy machine CyberKnife. This July, Ray became the first patient to be treated by the newly installed machine at The Royal Marsden. Ray, a grandfather of five from Fleet, Hampshire, needed just three sessions with CyberKnife, compared to the 35 sessions he received when he was initially treated with radiotherapy for prostate cancer. Three weeks after completing the treatment, his PSA (prostate-specific antigen) level reduced dramatically and will hopefully fall further. “I’m absolutely delighted with the results,” says Ray. “I couldn’t believe my luck when
12 RM MAgAzIne
they told me I would be the first patient to be offered this treatment. Previously, I went on the IMRT [intensity-modulated radiation therapy] trial and that gave me five years. If CyberKnife gives me another five, I’ll be a very happy man. “I was remarkably calm on the day of my first treatment,” recalls Ray. “It lasted about 45 minutes and was so restful. There was a lovely picture on the ceiling and I chose to listen to Susan Boyle and Johnny Cash. I think I actually fell asleep at one point. “It was so different to any other treatment I’ve had before. The CyberKnife robot moves around constantly. It could adjust to my body moving with my breathing or my bladder filling up. It’s hard for a layperson to take it on board or grasp how incredible it is. “I desperately wanted it to work for me and my family, but also for the CyberKnife team who worked so hard to make it possible. I wanted them to have success with me so they could feel even more confident with the next patient.” Ray, a self-employed plasterer, confirms that having fewer treatment sessions was also a huge benefit. “Last time, it seemed as if I was always visiting the hospital. This time, I went to work in the morning and then came to my appointment in the afternoon. It didn’t interfere with my life at all and I didn’t even experience any side-effects.” rm
CyberKnife has given me an extra chance and will hopefully do so for many other patients. It offers hope to a lot of people ray dean, the first cyberknife patient
Peter Ketteringham (left)
Patient case studies
The most impressive aspect of the treatment process was the quality of people who provide patient support peTeR KeTTeRinghaM, CybeRKnife paTienT
CyberKnife: effective treatment with minimal side-effects hen Peter Ketteringham, 69, was diagnosed with prostate cancer, the former engineer from Hampton was presented with a range of treatment methods, including surgery and internal and external radiotherapy. He opted to try CyberKnife. “CyberKnife seemed to offer the best balance between overall effectiveness and the minimisation of after-effects,” says Peter. “it was a logical development of existing, proven external radiation techniques made possible through the use of the latest technology. CyberKnife accurately focuses the radiation beam and tracks the moving
prostate, thus minimising any harmful effects of radiation on the healthy areas surrounding the prostate. The only real risk was that it’s a relatively new technique: there’s little UK data available to make comparisons with other techniques. However, i’m a great supporter of technological advances and felt that the opportunity outweighed the small risks. “i was impressed when i arrived for my first of five treatments. There’s a dedicated, comfortable lounge for you to relax in and the treatment room is extremely well appointed. although it’s dominated by the CyberKnife robot, i can’t think that anyone would find this room in any way intimidating – as is the case with some hospital treatments. “each of my five sessions lasted about an hour, which included positioning – an important part of the process. The robot arm whirls about your body while you lie back and try to relax. i soon got the hang of it. “i calculated that, including my journey to and from the hospital, the total time taken up by my CyberKnife treatment was 15 hours. more conventional external radiation treatment programmes can be 37 sessions: including travel, an equivalent time of more than 80 hours. i know which i’d prefer. “The most impressive aspect of the whole treatment process was the quality of people who provide the patient support and technical expertise. This made the whole process not only efficient and effective but, in a strange way, enjoyable. You wouldn’t choose to have the treatment unless it was necessary but i can’t think of a better environment in which to have it. “The real proof of the effectiveness of the treatment will be if the cancer is eliminated. in my case, it will be some time before my PSa readings will reveal if CyberKnife has done its job. i haven’t experienced other forms of cancer treatment, but i can’t see how anything can be better than CyberKnife from the patient’s point of view.” rm
patients are anticipated to receive CyberKnife treatment at The Royal Marsden in its first year
million raised by The Royal Marsden Cancer Charity to fund CyberKnife
CyberKnife sessions compared to 35 sessions of traditional radiotherapy (for Ray Dean)
RM magazine 13
Royal visit: a day to remember TRH The Duke and Duchess of Cambridge officially open the Oak Centre for Children and Young People
undreds of people, including staff, patients, our charityâ€™s supporters and the local community, gave TRH The Duke and Duchess of Cambridge a warm reception when they visited The Royal marsden, Sutton, in September to formally open our new Oak Centre for Children and Young People. The new centre is one of the largest of its kind in europe. it has 31 beds and will see almost 600 inpatients and more than 5,000 day patients every year. The brandnew facilities, together with state-of-the-art technology, provide increased capacity to help us meet growing demand and provide an environment for young patients that meets all their health, educational and social needs. The centre also houses a world-leading drug development programme, ensuring our young patients benefit from new cancer treatments and drugs that have been developed in our laboratories. During their visit, The Duke and Duchess spent more than two hours speaking to patients and staff inside the centre. in his speech before he and The Duchess officially unveiled the plaque, The Duke said âžœ
RM magazine 15
16â€‚ RM magazine
This place is inspirational. It really inspires me. As President of The Royal Marsden, I thank you from the bottom of my heart for making the idea of this magnificent new centre become a reality. It gives Catherine and me the greatest pleasure to declare it open HRH THe duke of cambRidge, pResidenT of THe Royal maRsden
RM magazine 17
he was honoured to open the new centre and was delighted to see the final results. Funding for the £18million facility was generously raised by The Royal Marsden Cancer Charity, with a contribution of £10million from the Oak Foundation and £3.5million from Teenage Cancer Trust for the Teenage Cancer Trust unit in the centre. The Duke told fundraising donors: “This place is inspirational. It really inspires me. As President of The Royal Marsden, I thank you from the bottom of my heart for making the idea of this magnificent new centre become a reality. It gives Catherine and me the greatest pleasure to declare it open.” Patient Alice Marples, 12, presented The Duchess with a bouquet. Alice first met The Duke two years ago when she interviewed him in a world exclusive for Newsround. “They were both so lovely to me and really caring,” she said. “We were delighted to welcome The Duke and Duchess of Cambridge to The Royal Marsden to open the new centre,” said Chief Executive Cally Palmer. “The event was a celebration of all the dedication and hard work by staff over the past two years to create such a wonderful new facility.” rm
To see more photographs and video footage of the day, visit royal marsden.nhs.uk
18 RM MAGAZINE
We were delighted to welcome The Duke and Duchess of Cambridge to The Royal Marsden to open the new centre. The event was a celebration of all the dedication and hard work by staff over the past two years to create such a wonderful new facility CALLY PALMER, CHIEF EXECUTIVE, THE ROYAL MARSDEN
RM MAGAZINE 19
Kate Hall, Matron and Service Manager for Private Care (this picture); private facilities at Granard House (right and below left); Professor Ian Judson, Head of the Sarcoma Unit and Professor of Cancer Pharmacology, with a patient (below right)
Private care feature
redevelopment programme update
Granard House reopens its doors
The Royal marsden’s private care wing officially reopened this summer following an expansion and refurbishment programme ranard House, the dedicated private care facility within The Royal marsden in Chelsea, is once more welcoming patients following a £6million renovation. There are now 21 single en-suite private rooms over three floors (an increase from 14 in the previous unit), and a refurbished outpatient suite with five consulting rooms and a comfortable, airy waiting area. Patients’ needs are at the heart of the rooms’ design, giving them as much control over their environment as possible: rooms are individually temperature-controlled and have a full entertainment system including TV and wireless internet access. Hospital staff, designers and architects all worked together to create a unique space that combines all the advantages of a modern clinical building with interiors that would promote patient wellbeing.
Designed with care
The beautiful Chelsea building has a wonderful heritage, but this did pose challenges. For example, each room is different. Hospital staff worked with designers on each unique layout, fitting bespoke furniture and using natural materials to create a restful, comfortable environment. “in granard House, our clinical staff work in the best possible environment,” says Kate Hall, matron and Service manager for Private Care. “everything has been built to the highest clinical and infection control standards to provide an exceptional standard of care.” Kerensa Heffron, Development Director
of Business and Private Practice, shares Kate’s enthusiasm: “i am thrilled the refurbished granard House is now open. a lot of work has gone into creating a space that is of the highest modern clinical standards, yet has a calm and cosy atmosphere to aid patients’ recovery.”
mr Paul Harris, Consultant Plastic Surgeon and Clinical Lead of the Department of Plastic and Reconstructive Surgery, agrees that the hospital environment is important. “There is clear evidence that the hospital environment can affect patient recovery. The Royal marsden has been investing heavily to improve patient facilities across the board. additional private facilities improve the care of insured and self-pay patients and free up space and operating time for nHS patients. “The facilities at granard House are superb; on the surface, they are more akin to a boutique hotel but, of course, underpinned by state-of-the-art healthcare design. The progressive approach taken by the hospital with respect to private practice is a model that should be replicated across the nHS.” rm
Everything has been built to the highest clinical and infection control standards to provide an exceptional standard of care kate hall, matron and service manager for private care
RM magazine 21
Jean Arjoon, Senior Staff Nurse – Theatres, prepares meticulously for surgery in one of the hospital’s seven theatres
22 RM magazine
a day in the life
Senior Staff Nurse – Theatres Jean Arjoon s a scrub nurse, i’m part of a larger team that consists of surgeons, anaesthetists, nurses, operating department practitioners (ODPs) and healthcare assistants. Together, we’re responsible for the care of all the patients in the operating theatre at any given time. Theatre operates on a scheduled basis whereby patients are booked for surgery and assigned a place on the operating list. There are seven theatres and a list may consist of one complex major operation taking 10 or more hours, or five or six minor or intermediate operations. my typical shift starts at 8am and ends at 6pm, although sometimes i work later if an operation overruns. i work directly with the surgeons, passing swabs, instruments, needles and any other items required during an operation. i’m also responsible for keeping count of all the items used throughout the procedure, and preparing and maintaining a sterile field before and during surgery. at the end of the operation, i ensure that the documentation of the patient’s care is correct and pass this to the staff of either the recovery room or the Critical Care Unit, depending on where we transfer the patient to. it’s a demanding role, with long and irregular hours, but also an incredibly rewarding one. Working as a team is
crucial because everyone has a specific task. For example, the ODP gets the patient to theatre and helps the anaesthetist put the patient to sleep. The anaesthetist monitors and maintains the patient during the operation, which in turn allows the surgeon to perform the procedure. Working in theatre often involves working directly with other departments to provide complete care for the patient. The majority of the patients come to theatre from the Day Surgery Unit, so there’s constant communication with the staff there on the arrival and preparation of patients for surgery. if an operation requires the use of X-ray, we liaise with the radiographer to ensure that they are there at the right time. after surgery, the patient may be transferred to the Critical Care Unit, where the level of care is closely monitored. The staff there must know when the patient will be arriving, so they can prepare in advance. This level of teamwork and interaction with other departments is vital to give the patient the complete care they need. The patient is under anaesthetic for most of the time, so you don’t get to know them as well as you might in some other roles. However, this makes us more aware of what we have to do to safeguard them and their dignity during the time they spend with us, which is something i take great pride in. rm
It’s a demanding role, with long and irregular hours, but also an incredibly rewarding one. Working as a team is crucial because everyone has a specific task
RM magazine 23
The royal marsden cancer chariTy
Marsden March 2012
A fantastic way to take on cancer
This is your chance to join celebrities, staff, supporters and patients in a walk that will make a real difference to more than 40,000 people treated by The Royal marsden each year
24 RM magazine
n its first year, The marsden march raised more than £820,000 – an amazing amount raised by just 2,000 walkers. We have double the amount of places in 2012: 3,000 for the full 14-mile walk and 1,000 for the shorter five-mile walk. it would be brilliant to break the millionpound mark next year. The marsden march is a fun 14-mile sponsored walk from our Chelsea hospital to our Sutton hospital and is suitable for people of all ages and fitness levels. it’s a great way for patients, staff, family and friends to come together to show their support for the cause and for the hospitals that mean
so much to them. The money raised will help to provide the best possible care and treatment for people with cancer. Former patient Claudia Shomade walked the 14-mile route earlier this year. “i had just been given the all-clear after five years,” says Claudia. “When i received an email to join The marsden march, i jumped at the opportunity. i wanted to give something back to the hospital. The Royal marsden gave me belief, support and the best fighting chance of beating cancer and watching my little girl grow up. She joined me for the last five miles and we met some special people, who i am sure we’ll see again next year.
“The event exceeded every expectation, and i feel blessed to be part of The marsden march. i’m already looking forward to the 2012 event – it will be another amazing day.” The second marsden march will take place on Sunday 11 march 2012. To sign up, visit royalmarsden.org/march
The Royal Marsden gave me belief, support and the best fighting chance of watching my little girl grow up claudia Shomade, former patient
Celebrate a Life the future of cancer treatment
Due to be completed in 2012, the new Centre for molecular Pathology will bring clinicians, geneticists, pathologists and scientists from The Royal marsden and The institute of Cancer Research together under one roof for the first time. The groundbreaking work to be carried out will improve outcomes for patients and make a huge difference to everyone affected by cancer. For more details and to see a short film, visit royalmarsden.org/cmp
Centre for Molecular Pathology
million funding to be raised by supporters of The Royal Marsden Cancer Charity
every year at The Royal marsden, we place thousands of stars on our Christmas trees – each one celebrating the life of a loved one. For a suggested donation of £15, you can add a star to one of our trees at either the Chelsea or Sutton hospital. You will also be invited to attend the Christmas tree lights switch-on ceremony, which takes place at 6pm on Tuesday 13 December in Sutton and Thursday 15 December in Chelsea, and a short carol service to celebrate the lives of those we love. if you plan to attend the carol
service, please complete the details online when you order your star. On the day, the name of your loved one will be written on a star and hung on your chosen tree at either site. We will also send you a special gold lapel star to thank you for your support. This Christmas, your generous gift will help us to fund vital state-of-the-art buildings and equipment, as well as our pioneering research into the prevention and treatment of cancer. Please order your star at royalmarsden.org/star
state-of-the-art floors housing world-leading pioneers, working under one roof
Refreshed charity website In October, the charity launched its inspiring new website. Go online to see where your money goes and how this makes such a difference to people facing cancer. The new site is easy to navigate and has lots of information about how to support the charity. Check it out at royalmarsden.org
celebrate a Life is a wonderful way to commemorate the lives of loved ones at christmas
RM magazine 25
CHELSEA AND SUTTON
Update: The Friends of The Royal Marsden
CHRISTMAS SELECTION There’s still time to buy your Christmas cards from The Royal Marsden Cancer Charity’s Christmas selection, featuring a wide range of cards, wrapping paper, 2012 diaries and pin badges. Order online by the end of November to ensure you receive your cards by mid-December. Alternatively,
visit our fundraising offices in Chelsea and Sutton during office hours and purchase cards any time until Christmas. There’s also a wide selection of charitybranded merchandise available from our online shop, from T-shirts to teddy bears. To order your Christmas goodies, visit royalmarsden.org/shop
Running and walking events in 2012 With the Olympics just around the corner, get into the spirit and set yourself a challenge in 2012. You could take part in one of The Royal Marsden Cancer Charity’s exciting running or walking events. We have places available in the following events:
11 March The Marsden March 15 April Brighton Marathon 22 April Virgin London Marathon 27 May BUPA London 10,000
The Friends, Chelsea Back in 2010, we were ferrying our goods around the wards on an ancient tea trolley with our wares in plastic baskets. Thanks to the proceeds of a fashion show, organised with the help of fashion designer Amanda Wakeley, the time was right for an upgrade. We first spoke to Rolls-Royce to see if it could help us design something special, but we were not local enough to Derby, where it is based. We then contacted the Women’s Royal Voluntary Service (WRVS) and, with its help, commissioned a trolley that would give us maximum product visibility and a more attractive display. Our amazing new trolley circulates the hospital twice a day selling snacks, cold drinks, magazines, newspapers, toiletries, cards and teddy bears. This year’s Christmas card range is now on sale at The Friends Shop next to the main reception, at The Friends canteen and on our trolleys. Don’t miss our Festival of Carols at Holy Trinity, Sloane Street on Tuesday 6 December at 6.45pm. Visit The Friends Office at Chelsea for tickets.
The Friends, Sutton With Christmas fast approaching, The Friends in Sutton will be busy in the shop and The Friends sale table in hospital Outpatients. Every year, the shop carries a wide range of seasonal goods including candles, soft toys and tinsel, as well as wrapping paper, bows and Christmas cards for children to colour in. If you’re looking for present ideas, why not pay us a visit? Our 99p ecopens make great stocking fillers. The Friends sale table holds a wide range of items, including our excellent selection of Christmas cards. All the proceeds are used to benefit patients of The Royal Marsden. If you have any unwanted new or good-as-new items, donations are always welcomed, from puzzles, stationery and toiletries to ornaments, DVDs and children’s books (excluding second-hand clothing and electrical equipment). The Friends rely on your donations to continue raising funds for the hospital. It really does make a difference – in 2010, the sale of donated books and other items raised more than £22,000.
The new-look Chelsea trolley
The Friends sale table at Sutton
For information about other challenge events, including cycle rides, treks and skydives, visit royalmarsden.org/challenges 26 RM MAGAZINE
THE IMPORTANCE OF HAND HYGIENE
Parking help for patients Members of the Patient and Carer Advisory Group (PCAG) have worked with the Royal Borough of Kensington and Chelsea to make seven on-street parking places near The Royal Marsden’s Chelsea site available for outpatients in need, particularly those receiving radiotherapy or chemotherapy. The parking spaces are only available for patients whose appointment will take up a substantial portion of the day, and can only be used on the day of the visit. With only
seven spaces available, the system operates on a ﬁrst-come, ﬁrst-served basis, and is for drivers who do not already hold a disabled parking permit. Mandie Adams McGuire, Chairman of PCAG, said: “This is another example of how PCAG, staff and volunteers at The Royal Marsden are working together to help patients.” For more information about parking, please contact Lisa Cane at the Wallace Wing Reception, Main Reception staff or the Facilities Ofﬁce team.
Good hand hygiene is a vital part of infection prevention in all areas of life and, most crucially, in hospitals. At The Royal Marsden, the Patient and Carer Advisory Group (PCAG) has been working with nursing staff to increase the awareness of the importance of hand hygiene, particularly among visitors. Paul Weaving, Lead Nurse for Infection Prevention and Control, spoke with PCAG members to discuss how the issue could be highlighted. It was agreed that members of PCAG would monitor the visibility of publicity material about hand washing around both sites, as well as work with Paul to consider voice messages and reminder notices in hospital lifts and at the entrances to wards and departments. Hand hygiene tips ◆ Disinfect your hands by washing them with soap and water at a sink, or by using the alcohol hand rub that’s widely available around the hospitals. Alcohol is less effective against some of the germs that cause gastroenteritis, so if the person you are seeing has loose bowels, wash your hands with soap and water after visiting. ◆ Disinfect your hands before entering and after leaving wards and departments – this ensures that you don’t take any unwanted presents into the ward or home again. ◆ Disinfect your hands before and after patient contact.
◆ Clean your hands if you have been in contact with contaminated surfaces, equipment or other items. ◆ Use liquid hand soap from sealed dispensers, as bar soap can harbour micro-organisms and should not be used in clinical settings. ◆ Cover any cuts or damaged skin on your hands with a waterproof plaster or other dressing – it must be waterproof because you still need to clean your hands. Alcohol hand rub may sting if it gets into cuts. ◆ The Royal Marsden dress code states that clinical staff in a clinical area must be ‘bare below the elbow’. Take off your coat, roll sleeves up above the elbows and take off your wristwatch and any other jewellery before washing your hands or using hand rub.
Alcohol handrub Please use the alcohol handr ub to disinfect your hands before entering and when leaving.
How to handrub 1
Rub hands palm to palm
Backs of ngers to opposing palms with ngers interlocked
Right palm over the back of the left hand with ngers interlaced and vice versa
Palm to palm with ngers interlaced
Rotational rubbing of left thumb clasped in right palm and vice versa
Rotational rubbing, backwards and forwards with clasped ngers of right hand in the left and vice versa
Alcohol handrub will kill most of the germs on your hands. Please use it to help keep our patients safe from infectio n.
RM MAGAZINE 27
foundation News Governors and Members assure improved quality
Patient Governor Hilary Bateson
In March, Members and Governors had the opportunity to air their views on the areas for improvement to inform the development of this year’s Quality Account for the Trust. As a result, the following themes were identified as priorities for improving the patient’s experience of care and were included in this year’s Quality Account: ◆ reduction in chemotherapy waiting times ◆ improvements in hospital transport ◆ information provision at every patient journey stage.
In the spotlight
The Patient Governor explains her role and the importance of representing the interests of patients in Greater London
Tell us about yourself i’m a governor representing greater London patients and i live at the very northern end of the area, on the border of Hertfordshire. i started my career in the publicity department of the BBC and spent the past 25 years in corporate communications for a large publishing company. in between, i spent three years with the Council of europe in Brussels and the Court of Human Rights in Strasbourg. although i’m now officially retired, i work as a research assistant to my husband, who is an author. Why did you stand for election to be a Governor? i was first diagnosed with breast cancer in 1985 so i have a long association with the hospital. it’s a wonderful place and i put myself forward as a governor to ‘give something back’. it’s been fascinating to learn about the hospital from the inside, and i’ve gained an enormous amount from the experience. 28 RM magazine
What are your main duties? We act as representatives of patients, carers and the public, and ensure that the interests of these groups are represented in the decisions made by the hospital board. in addition to the Council of governors meetings, i sit on the membership and Communications subcommittee. We’re looking at increasing membership so that as many patients, carers and members of the public as possible can share in the hospital’s future development and growth. i’m also part of the Patient experience Feedback group, led by Chief nurse Shelley Dolan. This group helps to formulate questionnaires to provide accurate feedback on the experience of both inpatients and outpatients so that any concerns can be addressed. There’s a really enthusiastic, positive atmosphere at all the meetings, and they provide a great opportunity to interact with both Royal marsden staff and fellow governors.
What are your aims as a Governor next year? all the changes in the nHS in 2012 and beyond will be seriously challenging for everyone involved. i look forward to being a small part of that challenge – there are interesting times ahead. What other challenges do you face as a Governor? The most difficult part is communicating directly with the members of the Trust. Our main face-to-face contact is at members’ events, which not all members are able to attend. Becoming a governor involves quite a learning curve for those of us with no previous experience of hospitals, except as a patient, but it’s an exciting and rewarding one. Why become a Member? You can get involved in the hospital, attend members’ events, meet up with other members, and influence plans for the hospital’s future. You also get a copy of Rm magazine.
All hospitals are required to publish an annual Quality Account to reflect the Trust’s performance. Governors receive regular reports on Quality Accounts at every Council of Governors meetings, so that they can monitor progress towards quality targets. A number of Governors are already looking at the process for agreeing the Quality Account for 2012–13, which will include Members’ input.
Become a Governor
In November, we will be inviting Public Members from ‘Elsewhere in England’ who do not live in Sutton & Merton or Kensington & Chelsea to nominate themselves to become a Royal Marsden Governor. The role of a Governor is to represent Members on the Council of Governors. Please contact the Foundation Trust Office for further details.
agM 2011 The Royal marsden nHS Foundation Trust annual general meeting (agm) took place on 28 September at The Royal marsden, Chelsea. Chairman R. ian molson welcomed guests, including Foundation Trust members and governors. governors formally received the 2010/11 annual Report and accounts as part of their legal duties in assuring the Trust and its membership. ian molson and Chief executive Cally Palmer both gave updates on the Trust’s developments and achievements over the past year, as well as plans for the year ahead. alan goldsman, Director of Finance, then provided a review of the Trust’s financial position and forecast for the future. There was also an opportunity to ask questions of the Trust Board. The Chairman and Chief executive thanked the work of the Council of governors in helping to assure the Trust and provide a voice to the views of Patient, Carer and Public members. The Trust also recognised the support members provided by attending events such as the agm. Highlight presentations included Professor andy Pearson talking about the Oak Centre for Children and Young People and Dr James Larkin presenting on ‘Breakthroughs in melanoma’, during which he spoke of world-leading discoveries at The Royal marsden that had been a step-change over generations.
Your Governors at a glance Patient Governors ◆ Paediatric and Adolescent Stacey Munns ◆ South West London Anita Gray, Fiona Stewart, Raelene Salter, Edward Crocker ◆ East Elmbridge & Mid-Surrey Dr James Laxton, Chris Pelley ◆ Greater London Dr Geoff Harding, Hilary Bateson ◆ Elsewhere in England Sally Mason, Vikki Orvice Carer Governors Lesley-Ann Gooden, John Preston, John Howard Public Governors Kensington & Chelsea Dr Carol Joseph ◆ Sutton & Merton Tony Hazeldine ◆ Elsewhere in England Ann Curtis ◆
The Trust’s Annual Plan
Looking ahead earlier this year, the Council of governors commented on the Trust’s annual Plan. This financial plan also sets out the Trust’s priorities under areas such as workforce, estates and capital and governance, all of which will underpin the delivery of the Trust’s strategy. The annual Plan is agreed by the Trust Board and submitted to monitor, the regulator of nHS Foundation Trusts, in line with the Trust’s compliance requirements. The Trust’s business strategy over the next three years focuses on four main themes: ◆ leadership of the concept of personalised medicine to improve diagnosis and
treatment using the latest techniques and discoveries ◆ the development of research and service partnerships to enhance innovation and extend The Royal marsden’s service to more people ◆ the development of more efficient clinical models and pathways ◆ the completion of the extensive capital programme to rebuild and modernise the Chelsea site and develop the Sutton site. governors regularly discuss these themes at Council of governor meetings. We will keep you updated on the Trust’s current projects and initiatives that support these themes in future issues of Rm magazine.
Dates for your diary Monday 5 December 2011 Council of Governors meeting, Board Room, Fulham Road, Chelsea Thursday 16 February 2012 Members’ Event, The Brookes Lawley Building, Institute of Cancer Research, Sutton Please contact the Foundation Office if you would like to attend
Staff Governors Doctor Professor Ian Smith ◆ Nurse Lorraine Hyde ◆ Other clinical professional Nina Kite ◆ Non-clinical Kim Andrews ◆
Nominated Governors Institute of Cancer Research vacant ◆ Primary Care Referrer Dr Chris Elliott ◆ South West London Cancer Network Alison Hill ◆ West London Cancer Network vacant ◆ London Borough of Kensington & Chelsea Councillor Robert Freeman ◆ Sutton & Merton PCT Dr Martyn Wake ◆ Croydon PCT vacant ◆ NHS Kensington & Chelsea Mable Wu ◆ Surrey PCT Michael Munt ◆ Cancer Research UK (charity) Dr Sally Burtles ◆ University Partner vacant
if you have any questions or would like to become a member, contact the Foundation Trust Office on 0800 587 7673 or email email@example.com RM magazine 29
PUZZLES & PRIZES
Test your wits
Complete our crossword and you could win a £50 John Lewis voucher SUDOKU
4 6 1 5 3 8 2 1 4 9 8 5 3 7 6 8
Dear RM, I was diagnosed with breast cancer in June 2001 and admitted to The Royal Marsden, Chelsea, for a lumpectomy, eight treatments of chemotherapy and radiotherapy. Ten years have passed and I have now been discharged from your care, although I can still contact you if I ever feel the necessity. I will miss you all. I would like to say how wonderful the care has been from every member of staff; too many to name. I couldn’t have wished for any more kindness than I received. I would like to say a special thank you to Research Nurse Angela Bradley, who has always been there for me at the end of the phone, if need be, and in person. Thank you all for everything. Best wishes, Janice Monk
2 1 6 4 4 2 1 5
Fill in your details below when sending in your crossword competition entry. See right for details of our address. NAME
Across 1 Comical (5) 4 Savour (5) 7 Freedom (7) 8 Regret (3) 9 Woodwind instrument (4) 11 Ire (5) 14 Valuable item (5) 15 Singing voice (4) 18 Large antelope (3) 19 Greed (7) 21 Force out (5) 22 Make comparison (5) Down 1 Bird of prey (6) 2 Seize suddenly (3) 3 Woolly story (4) 4 Attempting (6) 5 Dreamlike (7) 6 Level (4) 10 Vague (7) 12 Leave (6) 13 Fashionable (6) 16 Monster (4) 17 Shopping centre (4) 20 Writing ﬂuid (3) Congratulations to Mrs Pat Parr, who won the autumn issue’s crossword prize.
30 RM MAGAZINE
The lucky winner of our prize crossword will receive £50 of John Lewis vouchers. We also welcome your thoughts on RM magazine and love to hear about your experiences at the hospital. star letters win a £50 John Lewis voucher. Send your crossword or letter with your name and contact details to RM, Press Office, The Royal Marsden, Fulham Road, Chelsea, London SW3 6JJ. The closing date for entry is Monday 9 January 2012. See below for prize draw rules. PRIZE DRAWS & STAR LETTER TERMS & CONDITIONS: 1. The Prize Draws and Star Letter are open to all readers of RM except employees of the Press Ofﬁce at The Royal Marsden and Sunday, who produce RM magazine. 2. The closing date for receipt of all entries is Monday 9 January 2012. Only one entry per person per draw. 3. Responsibility cannot be accepted for entries which are incomplete, illegible or not received. Proof of posting is not proof of receipt. No cash alternative is available and prizes are not transferable. Value of prizes is correct at time of going to press. 4. Winners will be notiﬁed by post within 14 days of closing date. 5. The Promoter’s decision on any aspect of the promotions is ﬁnal and binding and no correspondence will be entered into. 6. The Promoter reserves the right to substitute a prize of equal or greater value should circumstances make this necessary. 7. Entry implies acceptance of rules. 8. The winner of the Star Letter prize of £50 of John Lewis vouchers is the sender of the best letter selected by RM magazine. 9. The winner of the crossword prize of £50 of John Lewis vouchers will be the ﬁrst correct entry drawn out of the bag. 10. The Promoter is The Royal Marsden Hospital, 203 Fulham Road, London SW3 6JJ.
in the next issue
RM brings you the latest hospital updates, research news, inspiring stories and exclusive interviews. The spring 2012 issue is coming soon…
Life demands excellence
magazine – autumn 2011
BUILDING FOR THE FUTURE
New developments at Sutton and Chelsea
CARING FOR YOUNG ADULTS
Tailoring the hospital experience for teenagers Life demands excellence
Serving the community Delivering high-quality patient care in the local area
magazine – spring 2011
Hospital updates / Foundation news / Carer support / Great prizes / Staff stories
Prostate cancer drug trials take major step forward
LIFE AFTER CANCER How we’re helping patients live with, and beyond, cancer
Our new Centre for Children and Young People is now open and leading the ﬁeld
Bowel cancer awareness in the spotlight
Hospital updates / Foundation news / Carer support / Great prizes / Staff stories
Redevelopment of Wallace Wing, Chelsea Horizon documentary Reader survey – what you said about RM magazine
For the royal Marsden Rachael Reeve – Director of Marketing and Communications Elaine Parr – PR and Communications Manager Belinda Payne – Senior Press Officer Catherine O’Mara – Senior Press Officer Marie-Thérèse Wright – Communications Assistant For sunday Lucy Ryan – Editor Marc Grainger – Sub Editor Catherine Hopkinson – Art Director Lindsay Williams – Account Director Matt Beaven – Creative Director Toby Smeeton – Managing Director RM magazine is published by The Royal Marsden in partnership with Sunday: sundaypublishing.com © The Royal Marsden 2011. All rights reserved. Reproduction in whole or part is prohibited without prior permission of the Editor. The Royal Marsden and Sunday accept no responsibility for the views expressed by contributors to the magazine. Repro by F1 Colour. Printed by Scanplus.
On Sunday 11 March, 4000 supporters, staff, family and friends will come together to take on cancer. Join us, put your best foot forward and walk the 14 miles between our Chelsea and Sutton hospitals. Walk with us, raise money and together weâ€™ll take on cancer. Places are filling up fast so please register as soon as possible if you want to walk with us in 2012. Please check our website for further information and to find out about other ways to get involved. Register today at www.royalmarsden.org/march Registered Charity No. 1095197
The Royal Marsden's magazine for staff, patients, carers and Foundation Trust Members.